Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
24.47
+0.20 (0.82%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $857.74 million as of April 28, 2026. Its market cap has increased by 1,445.54% in one year.
Market Cap
857.74M
Enterprise Value
705.21M
1-Year Change
1,445.54%
Ranking
Category
Stock Price
$24.47
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $857.74M, an increase of 62.24%. That is a compound annual growth rate of 24.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 850.73M | 53.84% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phathom Pharmaceuticals | 899.94M |
| LB Pharmaceuticals | 899.84M |
| CytomX Therapeutics | 896.90M |
| Xencor | 891.06M |
| Janux Therapeutics | 882.06M |
| SELLAS Life Sciences Group | 876.36M |
| Theravance Biopharma | 863.02M |
| MannKind | 861.54M |